Long-term effects of delayed-release dimethyl fumarate in multiple sclerosis: Interim analysis of ENDORSE, a randomized extension study

BACKGROUND: Delayed-release dimethyl fumarate (DMF) demonstrated strong efficacy and a favorable benefit–risk profile for patients with relapsing–remitting multiple sclerosis (RRMS) in phase 3 DEFINE/CONFIRM studies. ENDORSE is an ongoing long-term extension of DEFINE/CONFIRM. OBJECTIVE: We report e...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Mult Scler
Main Authors: Gold, Ralf, Arnold, Douglas L, Bar-Or, Amit, Hutchinson, Michael, Kappos, Ludwig, Havrdova, Eva, MacManus, David G, Yousry, Tarek A, Pozzilli, Carlo, Selmaj, Krysztof, Sweetser, Marianne T, Zhang, Ray, Yang, Minhua, Potts, James, Novas, Mark, Miller, David H, Kurukulasuriya, Nuwan C, Fox, Robert J, Phillips, Theodore J
Formato: Artigo
Idioma:Inglês
Publicado em: SAGE Publications 2016
Assuntos:
Original Research Papers
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5418934/
https://ncbi.nlm.nih.gov/pubmed/27207449
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1352458516649037
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados